Cribstone Capital Management’s Biogen BIIB Stock Holding History

Cribstone Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-74	Closed	-$17K	–	562
2019 Q2	$17K	Hold	74	–	–	0.01%	372
2019 Q1	$17K	Hold	74	–	–	0.01%	385
2018 Q4	$22K	Hold	74	–	–	0.01%	359
2018 Q3	$26K	Hold	74	–	–	0.01%	354
2018 Q2	$21K	Hold	74	–	–	0.01%	386
2018 Q1	$20K	Buy	74 +9	+14%	+$2.79K	0.01%	383
2017 Q4	$21K	Hold	65	–	–	0.01%	441
2017 Q3	$20K	Hold	65	–	–	0.01%	400
2017 Q2	$18K	Hold	65	–	–	0.01%	416
2017 Q1	$17K	Hold	65	–	–	0.01%	449
2016 Q4	$18K	Hold	65	–	–	0.01%	411
2016 Q3	$19K	Sell	65 -25	-28%	-$7.4K	0.01%	414
2016 Q2	$22K	Buy	+90	New	+$23.7K	0.01%	406

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cribstone Capital Management's BIIB Position: Q3 2019 in Review

Cribstone Capital Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 74 shares — an estimated $17K sold.

Cribstone Capital Management first reported a position in BIIB in Q2 2016 and held it in 13 quarters. The position peaked at $26K in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Cribstone Capital Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Cribstone Capital Management sold 74 Biogen shares in Q3 2019, an estimated $17K.
Cribstone Capital Management first reported a position in Biogen in Q2 2016 and held it in 13 quarters.
Cribstone Capital Management's Biogen position peaked at $26K in Q3 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Cribstone Capital Management's 13F filing for Q3 2019, filed 20 Nov 2019.